Recent Quotes
My Watchlist
Indicators
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Stevanato Group S.p.A. Ordinary Shares (NY:STVN)

18.02 -0.08 (-0.44%)
Streaming Delayed Price Updated: 10:22 AM EDT, Jun 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Stevanato Group S.p.A. Ordinary Shares

< Previous 1 2 3 4 Next >
News headline image
Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management
From Stevanato Group
Via Business Wire
News headline image
Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group to Participate in Three Upcoming Investor Conferences
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026
From Stevanato Group
Via Business Wire
News headline image
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026
From Stevanato Group
Via Business Wire
News headline image
Stevanato Group Reports Revenue of €303.2 Million for the Third Quarter of 2025
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group to Participate in Upcoming Investor Conferences
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group to Report Third Quarter 2025 Financial Results on November 6, 2025
From Stevanato Group
Via Business Wire
News headline image
Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings
From Stevanato Group
Via Business Wire
News headline image
Stevanato Group to Participate in Upcoming Investor Conferences
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S.
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group to Participate in Upcoming Investor Conferences
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025
From Stevanato Group
Via Business Wire
News headline image
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
From Stevanato Group
Via Business Wire
News headline image
Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025
From Stevanato Group
Via Business Wire
News headline image
Stevanato Group to Present at Upcoming Investor Conference
From Stevanato Group
Via Business Wire
News headline image
Stevanato Group to Present at Upcoming Investor Conferences
From Stevanato Group
Via Business Wire
News headline image
Stevanato Group Reports Financial Results for the Third Quarter of 2024
From Stevanato Group
Via Business Wire
News headline image
Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan
From Stevanato Group
Via Business Wire
News headline image
Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU”
From Stevanato Group
Via Business Wire
News headline image
Stevanato Group to Present at Upcoming Investor Conferences
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group Reports Financial Results for the Second Quarter of 2024
From Stevanato Group S.p.A.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.